1. Home
  2. EXPI vs KALV Comparison

EXPI vs KALV Comparison

Compare EXPI & KALV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo eXp World Holdings Inc.

EXPI

eXp World Holdings Inc.

HOLD

Current Price

$6.72

Market Cap

1.0B

Sector

Finance

ML Signal

HOLD

Logo KalVista Pharmaceuticals Inc.

KALV

KalVista Pharmaceuticals Inc.

HOLD

Current Price

$20.86

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EXPI
KALV
Founded
2008
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.0B
IPO Year
2010
2014

Fundamental Metrics

Financial Performance
Metric
EXPI
KALV
Price
$6.72
$20.86
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
5
Target Price
$9.75
$32.60
AVG Volume (30 Days)
875.3K
1.2M
Earning Date
05-05-2026
05-09-2026
Dividend Yield
3.00%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$500,147,681.00
$50,000,000.00
Revenue This Year
$6.26
$187.19
Revenue Next Year
$5.50
$54.93
P/E Ratio
N/A
N/A
Revenue Growth
220.39
495.66
52 Week Low
$5.66
$9.83
52 Week High
$12.23
$21.31

Technical Indicators

Market Signals
Indicator
EXPI
KALV
Relative Strength Index (RSI) 62.47 61.63
Support Level $5.68 $14.66
Resistance Level $11.36 $21.31
Average True Range (ATR) 0.23 1.22
MACD 0.14 0.01
Stochastic Oscillator 98.07 83.59

Price Performance

Historical Comparison
EXPI
KALV

About EXPI eXp World Holdings Inc.

eXp World Holdings Inc is a cloud-based residential real estate company. The company owns and operates a cloud-based real estate brokerage and a technology platform business that develops and uses immersive technologies that help businesses increase their effectiveness and reduce costs from operating in traditional brick-and-mortar office spaces. Its business categories include Real Estate Brokerage, Technology Products and Services, Title, Escrow, Settlement Services, and Mortgage Brokerage Services.

About KALV KalVista Pharmaceuticals Inc.

KalVista Pharmaceuticals Inc is a pharmaceutical company developing and delivering oral therapies for individuals affected by rare diseases with unmet needs. The company applies its knowledge in the kallikrein-kinin system (KKS) and oral drug discovery to develop small-molecule protease inhibitor medicines to address the needs of patients with diseases driven by plasma kallikrein and Factor XIIa. Its FDA-approved product EKTERLY (sebetralstat) is a novel, orally delivered, small-molecule plasma kallikrein inhibitor for the treatment of acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged twelve years and older.

Share on Social Networks: